All Stories

  1. Structure-Guided Repurposing of Approved Drugs Identifies Aprepitant and Mavorixafor as Putative δ-Opioid Receptor Agonist Candidates
  2. Multifunctional Halloysite-Glutathione Nanocomposite for Solar CO2 Conversion and Pollutant Sensing
  3. Repurposing FDA-approved drugs as SIRT3-binding candidates for Ataxia–Telangiectasia: An integrated virtual screening, molecular dynamics, and SPR study
  4. Tunable phenolic-modified alginate–chitosan semi-IPNs as multifunctional platforms for localized antimicrobial and antioxidant therapy
  5. Targeting the untargetable: accelerated discovery of KRAS G12D inhibitors through a deep learning-enhanced in silico pipeline
  6. High-Throughput, High-Quality: Benchmarking GNINA and AutoDock Vina for Precision Virtual Screening Workflow
  7. Nanosensors Made of Halloysite and Kojic Acid Metal Complexes for Dopamine Detection
  8. Development of a γ-Cyclodextrin-Based Cryogel Loaded with Trimethoprim for Acne Treatment: Design, Synthesis, and In Vitro Evaluation
  9. High-Throughput, High-Quality: Unlocking GNINA for Precision Virtual Screening
  10. Designing a monolithic photo-Fenton catalyst using a fungal hydroxypyrone metabolic derivative
  11. Selective Control by Pistacia vera L. and Its Carotenoid Zeaxanthin on SARS-CoV-2 Virus
  12. Enhancing HDAC Inhibitor Screening: Addressing Zinc Parameterization and Ligand Protonation in Docking Studies
  13. A full carbon-based thermoplastic photocatalyst for organic pollutants abatement: An experimental and computational study
  14. Carboxylato-prism[6]arene as a supramolecular catalyst in water: exploiting its deep hydrophobic cavity for green oxidation of aromatic amines
  15. Enhancing HDAC Inhibitors Screening: Addressing Zinc Parameterization and Ligand Protonation in Docking Studies
  16. Design, Synthesis, and Evaluation of Novel (−)‐cis‐N‐Normetazocine Derivatives: In Vitro and Molecular Modeling Insights
  17. Developing Advanced Antibacterial Alginic Acid Biomaterials through Dual Functionalization
  18. Efficient green solvent-free CO2/epoxide cycloaddition catalyzed by a β-cyclodextrin-imidazolium-based ionic liquid
  19. Synthesis, Characterisation, and In Vitro Evaluation of Biocompatibility, Antibacterial and Antitumor Activity of Imidazolium Ionic Liquids
  20. Structural, morphological, and modeling studies of N-(benzoyloxy)benzamide as a specific inhibitor of Type II inosine monophosphate dehydrogenase
  21. CYP7B1 as a Biomarker for Prostate Cancer Risk and Progression: Metabolic and Oncogenic Signatures (Diagnostic Immunohistochemistry Analysis by Tissue Microarray in Prostate Cancer Patients—Diamond Study)
  22. Targeting Viral and Cellular Cysteine Proteases for Treatment of New Variants of SARS-CoV-2
  23. Rutin/Sulfobutylether-β-Cyclodextrin as a Promising Therapeutic Formulation for Ocular Infection
  24. Rutin/Sulfobutylether-β-Cyclodextrin as a Promising Therapeutic Formulation for Ocular Infection
  25. γ‐Cyclodextrins as Supramolecular Reactors for the Three‐component Aza‐Darzens Reaction in Water
  26. Supramolecular biomaterials as drug nanocontainers with iron depletion properties for antimicrobial applications
  27. Bio-Based Palladium Catalyst in Cryogel for Cross-Coupling Reactions
  28. An Integrated In Silico and In Vitro Approach for the Identification of Natural Products Active against SARS-CoV-2
  29. Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity
  30. Antiviral Efficacy of Heparan Sulfate and Enoxaparin Sodium against SARS-CoV-2: An In-Vitro/in-Silico Model
  31. HEMA-based macro and microporous materials for CO2 capture
  32. Insights into the Friedel–Crafts Benzoylation of N-Methylpyrrole inside the Confined Space of the Self-Assembled Resorcinarene Capsule
  33. How can artificial intelligence be utilized for de novo drug design against COVID-19 (SARS-CoV-2)?
  34. Total Bio-Based Material for Drug Delivery and Iron Chelation to Fight Cancer through Antimicrobial Activity
  35. Total Bio-Based Material To Fight Cancer Through Antimicrobial Activity
  36. Progress of the “Molecular Informatics” Section in 2022
  37. Selective noncovalent proteasome inhibiting activity of trifluoromethyl‐containing gem‐quaternary aziridines
  38. Computer-Assisted Design of Peptide-Based Radiotracers
  39. Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors
  40. Design, synthesis, in vitro evaluation, and molecular modeling studies of N‐substituted benzomorphans, analogs of LP2, as novel MOR ligands
  41. Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43
  42. Portable Nanocomposite System for Wound Healing in Space
  43. Soluble peptidoglycan fragments produced by Limosilactobacillus fermentum with antiproliferative activity are suitable for potential therapeutic development: A preliminary report
  44. 1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study
  45. Sponge-like macroporous cyclodextrin-based cryogels for controlled drug delivery
  46. CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications
  47. Carbamoyl-Decorated Cyclodextrins for Carbon Dioxide Adsorption
  48. Cyclodextrin-Based Cryogels for Controlled Drug Delivery
  49. Novel Class of Proteasome Inhibitors: In Silico and In Vitro Evaluation of Diverse Chloro(trifluoromethyl)aziridines
  50. Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022
  51. Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process
  52. Correction to “Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents”
  53. Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia
  54. Artificial Intelligence Technologies for COVID-19 De Novo Drug Design
  55. Artificial Intelligence Technologies for COVID-19 De Novo Drug Design
  56. A sustainable porous composite material based on loofah-halloysite for gas adsorption and drug delivery
  57. Carbocation catalysis in confined space: activation of trityl chloride inside the hexameric resorcinarene capsule
  58. Supramolecular catalysis in confined space: making the pyrogallol[4]arene capsule catalytically active in non-competitive solvent
  59. Green Efficient One-Pot Synthesis and Separation of Nitrones in Water Assisted by a Self-Assembled Nanoreactor
  60. Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties
  61. From Far West to East: Joining the Molecular Architecture of Imidazole-like Ligands in HO-1 Complexes
  62. Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological Aspects
  63. Growing the molecular architecture of imidazole-like ligands in HO-1 complexes
  64. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose
  65. Unusual Calixarenes Incorporating Chromene and Benzofuran Moieties Obtained via Propargyl Claisen Rearrangement
  66. Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent In Vitro Antiproliferative Activity
  67. Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents
  68. Shedding Light on the Chemistry and the Properties of Münchnone Functionalized Graphene
  69. Expanding Coefficient: A Parameter To Assess the Stability of Induced-Fit Complexes
  70. Pseudo-Dipeptide Bearing α,α-Difluoromethyl Ketone Moiety as Electrophilic Warhead with Activity against Coronaviruses
  71. Nanosponges based on self-assembled starfish-shaped cucurbit[6]urils functionalized with imidazolium arms
  72. An Integrated Pharmacophore/Docking/3D-QSAR Approach to Screening a Large Library of Products in Search of Future Botulinum Neurotoxin A Inhibitors
  73. Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region
  74. A Rare Natural Benzo[k,l]xanthene as a Turn-Off Fluorescent Sensor for Cu2+ Ion
  75. New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine
  76. Functionalization of Single and Multi-Walled Carbon Nanotubes with Polypropylene Glycol Decorated Pyrrole for the Development of Doxorubicin Nano-Conveyors for Cancer Drug Delivery
  77. Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study
  78. Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation
  79. Inhibitors of SARS-CoV-2 Main Protease from a Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study
  80. New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells
  81. Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers
  82. Cucurbit[7]uril as a catalytic nanoreactor for one-pot synthesis of isoxazolidines in water
  83. Repurposing of FDA‐Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D‐QSAR/Docking Approach†
  84. Progress in the development of more effective and safer analgesics for pain management
  85. [1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT7 receptor
  86. Synergic Interplay Between Halogen Bonding and Hydrogen Bonding in the Activation of a Neutral Substrate in a Nanoconfined Space
  87. Synergic Interplay Between Halogen Bonding and Hydrogen Bonding in the Activation of a Neutral Substrate in a Nanoconfined Space
  88. Supramolecular host-guest interactions of pseudoginsenoside F11 with β- and γ-cyclodextrin: Spectroscopic/spectrometric and computational studies
  89. Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach
  90. Physicochemical Characterization and Antioxidant Activity Evaluation of Idebenone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex †
  91. Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach
  92. Metabolic Characterization of Supernatants Produced by Lactobacillus spp. With in vitro Anti-Legionella Activity
  93. Structure-Based Approach for the Prediction of Mu-opioid Binding Affinity of Unclassified Designer Fentanyl-Like Molecules
  94. A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light
  95. Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application
  96. 3D-QSAR assisted identification of FABP4 inhibitors: An effective scaffold hopping analysis/QSAR evaluation
  97. Hydroxamic Acid-Based Histone Deacetylase (HDAC) Inhibitors Bearing a Pyrazole Scaffold and a Cinnamoyl Linker
  98. Synthesis of Rosmarinic Acid Amides as Antioxidative and Hypoglycemic Agents
  99. Fourfold Filtered Statistical/Computational Approach for the Identification of Imidazole Compounds as HO-1 Inhibitors from Natural Products
  100. FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets
  101. Gemcitabine anticancer activity enhancement by water soluble celecoxib/sulfobutyl ether-β-cyclodextrin inclusion complex
  102. Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands
  103. A hexameric resorcinarene capsule as a hydrogen bonding catalyst in the conjugate addition of pyrroles and indoles to nitroalkenes
  104. Metyrapone-β-cyclodextrin supramolecular interactions inferred by complementary spectroscopic/spectrometric and computational studies
  105. A Pseudouridine Isoxazolidinyl Nucleoside Analogue Structural Analysis: A Morphological Approach
  106. Development of new HO-1 inhibitors by a thorough scaffold-hopping analysis
  107. A Structure- and Ligand-Based Virtual Screening of a Database of “Small” Marine Natural Products for the Identification of “Blue” Sigma-2 Receptor Ligands
  108. Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines
  109. Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis
  110. PEGylate porphyrin-gold nanoparticles conjugates as removable pH-sensor nano-probes for acidic environments
  111. Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis
  112. Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D‐QSAR Coupled to Scaffold‐Hopping Analysis
  113. Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation
  114. Light‐Controlled Simultaneous “On Demand” Release of Cytotoxic Combinations for Bimodal Killing of Cancer Cells
  115. Mild Friedel–Crafts Reactions inside a Hexameric Resorcinarene Capsule: C−Cl Bond Activation through Hydrogen Bonding to Bridging Water Molecules
  116. Mild Friedel–Crafts Reactions inside a Hexameric Resorcinarene Capsule: C−Cl Bond Activation through Hydrogen Bonding to Bridging Water Molecules
  117. Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors
  118. Covalently immobilized catalase on functionalized graphene: effect on the activity, immobilization efficiency, and tetramer stability
  119. DNA intercalators based on (1,10-phenanthrolin-2-yl)isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma
  120. Bio-activated intramolecular anti-aza-Michael addition: stereoselective synthesis of hydantoin derivatives
  121. The hexameric resorcinarene capsule as an artificial enzyme: ruling the regio and stereochemistry of a 1,3-dipolar cycloaddition between nitrones and unsaturated aldehydes
  122. (+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties
  123. Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents
  124. Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors
  125. Serendipitous discovery of potent human head and neck squamous cell carcinoma anti-cancer molecules: A fortunate failure of a rational molecular design
  126. Ensemble-based ADME-Tox profiling and virtual screening for the discovery of new inhibitors of the Leishmania mexicana cysteine protease CPB2.8ΔCTE
  127. Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5ʹ-monophosphate glycosidase
  128. Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands
  129. Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents
  130. Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review
  131. Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors
  132. Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis
  133. Sigma-2 receptor ligands QSAR model dataset
  134. Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases
  135. γ-Cyclodextrin as a Catalyst for the Synthesis of 2-Methyl-3,5-diarylisoxazolidines in Water
  136. The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
  137. S2RSLDB: a comprehensive manually curated, internet-accessible database of the sigma-2 receptor selective ligands
  138. Antiangiogenic Effect of (±)-Haloperidol Metabolite II Valproate Ester [(±)-MRJF22] in Human Microvascular Retinal Endothelial Cells
  139. 5′-Spiro-cyclopropanated lactose derivatives as suitable intermediates for the chain elongation: synthesis of a new 6-deoxy-6-methyl δ-eptulose
  140. Synthesis and characterization of copolycarbonates having azobenzene units in the main chain as an active group for optical logic gate devices
  141. Targeting of the Leishmania mexicana cysteine protease CPB2.8ΔCTE by decorated fused benzo[b]thiophene scaffold
  142. Decorated 6,6′,7,7′-tetrahydro-1H,1′H-2,3′-biindole scaffold as promising candidate for recognition of the CDK2 allosteric site
  143. An α1-adrenergic receptor ligand repurposed as a potent antiproliferative agent for head and neck squamous cell carcinoma
  144. Haloperidol metabolite II prodrug: Asymmetric synthesis and biological evaluation on rat C6 glioma cells
  145. 4-Nitro-2,1,3-benzoxadiazole derivatives as potential fluorescent sigma receptor probes
  146. Repurposing of oxazolone chemistry: gaining access to functionalized graphene nanosheets in a top-down approach from graphite
  147. DNA Recognition with Polycyclic-Aromatic-Hydrocarbon-Presenting Calixarene Conjugates
  148. Production of filmable medium-chain-length polyhydroxyalkanoates produced from glycerol by Pseudomonas mediterranea
  149. Use of Microwave Heating in the Synthesis of Heterocycles from Carbohydrates
  150. Recent advances in small organic molecules as DNA intercalating agents: Synthesis, activity, and modeling
  151. A top–down approach to crystal engineering of a racemic Δ2-isoxazoline
  152. Functional hybrid co-crystals of humic substances: a growth forecast
  153. Prevalence of Oxetanose Forms in the Tautomeric Equilibrium of β-Hydroxy-1,5-dicarbonyl Monosaccharides
  154. Self-Catalyzed Mannich-Type Reaction of Enolizable Cyclic 1,3-Dicarbonyls to Acyclic Nitrones: An Entry to Functionalized β-Enamino Diones
  155. Phosphonated Nucleoside Analogues
  156. Experimental and in silico characterization of a biologically active inosose
  157. Crystal Morphologies and Polymorphs in Tolbutamide Microcrystalline Powder
  158. Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment
  159. Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment
  160. Synthesis and biological activity of novel bifunctional isoxazolidinyl polycyclic aromatic hydrocarbons
  161. Novel isoxazole polycyclic aromatic hydrocarbons as DNA-intercalating agents
  162. Potassium caffeate/caffeic acid co-crystal: the rat race between the catecholic and carboxylic moieties in an atypical co-crystal
  163. Recent Developments on Rotaxane-Based Shuttles: An Update to 2010
  164. How molecular interactions affect crystal morphology: The case of haloperidol
  165. Design, Synthesis, Molecular Docking and Crystal Structure Prediction of New Azasugar Analogues of α-Glucosidase Inhibitors
  166. From the X-rays to a reliable “low cost” computational structure of caffeic acid: DFT, MP2, HF and integrated molecular dynamics–X-ray diffraction approach to condensed phases
  167. An intriguing U-shaped molecule as possible ionophore for sensor applications: A computational DFT and NMR study
  168. Isoxazolidinyl polycyclic aromatic hydrocarbons as DNA-intercalating antitumor agents
  169. Stereodefined ring contraction-rearrangement of thiocoumarins to new fused benzo[b]thiophene derivatives
  170. β-Cyclodextrin and Caffeine Complexes with Natural Polyphenols from Olive and Olive Oils: NMR, Thermodynamic, and Molecular Modeling Studies
  171. Could N-(diethylcarbamothioyl)benzamide be a good ionophore for sensor membranes?
  172. Structural determinants of resveratrol for cell proliferation inhibition potency: Experimental and docking studies of new analogs
  173. Synthesis of C-4′Truncated Phosphonated Carbocyclic 2′-Oxa-3′-azanucleosides as Antiviral Agents
  174. Biomimetic Synthesis of Natural and “Unnatural” Lignans by Oxidative Coupling of Caffeic Esters
  175. Stereoselective Synthesis and Biological Evaluations of Novel 3′-Deoxy-4′-azaribonucleosides as Inhibitors of Hepatitis C Virus RNA Replication
  176. Structures and properties in different media of N,N-(diethylcarbamothioyl)furan-2-carboxamide: A ionophore for sensor membranes
  177. Recent Developments on Rotaxane-Based Shuttles
  178. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication
  179. Cyclopropanation of 5-methylene galactopyranosides by dihalo-, ethoxycarbonyl-, and unsubstituted carbenes
  180. Conversion of Oximes to Carbonyl Compounds by Triscetylpyridinium Tetrakis(oxodiperoxotungsto) Phosphate (PCWP)-mediated Oxidation with Hydrogen Peroxide
  181. Synthesis of Methyleneisoxazolidine Nucleoside Analogues by Microwave-Assisted Nitrone Cycloaddition
  182. Phosphonated Carbocyclic 2‘-Oxa-3‘-azanucleosides as New Antiretroviral Agents
  183. A Novel Class of Modified Nucleosides: Synthesis of Alkylidene Isoxazolidinyl Nucleosides Containing Thymine
  184. A DFT study on the 1,3-dipolar cycloaddition reactions of C-(hetaryl) nitrones with methyl acrylate and vinyl acetate
  185. Synthesis and biological evaluation of phosphonated carbocyclic 2′-oxa-3′-aza-nucleosides
  186. Binding of a non-ionic pyrenylisoxazolidine derivative to double-stranded polynucleotides: spectroscopic and molecular modelling studies
  187. Synthesis and Biological Activity of Isoxazolidinyl Polycyclic Aromatic Hydrocarbons:  Potential DNA Intercalators
  188. Corrigendum to “Enantioselective synthesis of N,O-psiconucleosides”
  189. Zinc(II) Triflate-Controlled 1,3-Dipolar Cycloadditions of C -(2-Thiazolyl)nitrones:  Application to the Synthesis of a Novel Isoxazolidinyl Analogue of Tiazofurin
  190. Synthesis of functionalized polyhedral oligomeric silsesquioxane (POSS) macromers by microwave assisted 1,3-dipolar cycloaddition
  191. From Amino Acids to Enantiopure Bicyclic Isoxazolidinylpyridin-4(1H)-ones through Intramolecular Nitrone Cycloadditions
  192. Synthesis of Phosphonated Carbocyclic 2‘-Oxa-3‘-aza-nucleosides:  Novel Inhibitors of Reverse Transcriptase
  193. Reactions of Benzonitrile Oxide with Methoxypyrimidines and Pyrimidones
  194. C-Alkoxycarbonyl Nitrones: Building Blocks for the Synthesis of Butenolides, Lactams and Modified Nucleosides
  195. Synthesis of pyrimidine-containing 3-aminobutenolides
  196. A DFT rationalization for the observed regiochemistry in the nitrile oxide cycloaddition with anthracene and acridine
  197. From cyclopentadiene to isoxazoline–carbocyclic nucleosides: a rapid access to biological molecules through nitrosocarbonyl chemistry
  198. Steric course of some cyclopropanation reactions of L-threo-hex-4-enopyranosides
  199. Diastereoselective synthesis of homo-N,O-nucleosides
  200. Diastereo- and Enantioselective Synthesis of 1′-C-BranchedN,O-Nucleosides
  201. Diastereo- and enantioselective synthesis of N,O-nucleosides
  202. Enantioselective synthesis of N,O-psiconucleosides
  203. Enantioselective Syntheses and Cytotoxicity ofN,O-Nucleosides
  204. Isoxazolidine analogues of pseudouridine: a new class of modified nucleosides
  205. A DFT study on the 1,3-dipolar cycloaddition reactions of C-(methoxycarbonyl)-N-methyl nitrone with methyl acrylate and vinyl acetate
  206. New Rearrangement of 4-Isoxazoline System:  Conversion of Ketones into α,β-Unsaturated Amides
  207. Enantioselective synthesis of isoxazolidinyl nucleosides containing uracil, 5-fluorouracil, thymine and cytosine as new potential anti-HIV drugs
  208. Syntheses of new chiral bicyclic sultams and their use as auxiliaries in asymmetric conjugate addition of Grignard reagents
  209. Intramolecular Cycloadditions of α-Allyloxycarbonylnitrones:  Stereoselective Synthesis of 3-Amino-2(5H)furanones
  210. Diastereoselective Synthesis ofN,O-Psiconucleosides, a New Class of Modified Nucleosides
  211. Enantioselective synthesis of 4-hydroxy-d-pyroglutamic acid derivatives by an asymmetric 1,3-dipolar cycloaddition
  212. Modified nucleosides. A general and diastereoselective approach to N,O-psiconucleosides
  213. A Stereoselective Approach to Isoxazolidinyl Nucleosides
  214. Stereoselective synthesis of homochiral annulated sultams via intramolecular cycloaddition reactions
  215. Diastereoselective synthesis of N,O-psiconucleosides via 1,3-dipolar cycloadditions
  216. Diastereoselective and enantioselective synthesis of 4′-aza analogues of 2′,3′-dideoxynucleosides
  217. Cycloadditions of mesitonitrile oxide with amino- and nitrostilbenes†
  218. An Unusual Route for the Regioselective Acylation of Polycyclic Aromatic Hydrocarbons: Nitrile Oxide Addition Followed by Isoxazoline Degradation
  219. Homochiral α-d- and β-d-Isoxazolidinylthymidines via 1,3-Dipolar Cycloaddition†
  220. Stereoselective Synthesis of Enantiomerically Pure Isoxa-zolidine-fused d-Lactams
  221. Stereoselective Synthesis of 2‘-Amino-2‘,3‘-dideoxynucleosides by Nitrone 1,3-Dipolar Cycloaddition:  A New Efficient Entry Toward d4T and Its 2-Methyl Analogue †
  222. Cycloaddition of nitrile oxides to aza-analogues of phenanthrene
  223. A general synthetic approach to 5-alkyl-2(5H)furanonesvia 1,3-dipolar cycloaddition
  224. THE REACTION OF UNSATURATED CARBONYL COMPOUNDS WITH "ACTIVATED" SULFUR PART 3.1 REACTION COURSE
  225. The Reaction of Unsaturated Carbonyl Compounds with “Activated” Sulfur. Part 3.1Reaction Course
  226. The Reaction of Unsaturated Carbonyl Compounds with "Activated" Sulfur (II). Formation of Cyclic Disulfide and Polysulfides
  227. Cycloadditions of Mesitonitrile Oxide with Hydroxy- and Methoxy-substituted Stilbenes. A Directing Hydrogen Bonding Model
  228. Biomimetic Supramolecular Biophenol−Carbohydrate and Biophenol−Protein Models by NMR Experiments
  229. Stereoselective synthesis of isoxazole and pyrazole annulated sultams via intramolecular 1,3-dipolar cycloaddition reactions
  230. Intramolecular nitrone cycloaddition: Stereoselective synthesis of piperidine systems
  231. Intramolecular nitrile oxide cycloaddition (INOC) of substituted amido-oximes
  232. An asymmetric approach to pyrrolidinone and pyrrolizidinone systems by intramolecular oxime-olefin cycloaddition
  233. Modified dideoxynucleosides: Synthesis of 2′-N-alkyl-3′-hydroxyalkyl-1′,2′-isoxazolidinyl thymidine and 5-fluorouridine derivatives
  234. Synthesis of 1-alkyl-3-dialkylaminoalkylamine[1]benzo-thieno[2,3-b]pyrazin-2(1H))-ones and their ability to antagonize KCl-induced contractions
  235. Ring opening of the isoxazolidine system: A new synthesis of 3-amino-2(5H)furanones
  236. α-Amino acids as chiral educts for stereoselective syntheses of pyrrolidine and pyrrolizidine systems
  237. Ring-opening of isoxazolidine nucleus: Competitive formation of α,β-enones and tetrahydro-1,3-oxazines
  238. Stereoselective synthesis of fused γ-lactams by intramolecular nitrone cycloaddition
  239. Stereoselective control in 1,3-dipolar cycloaddition of nitrones to substituted styrenes
  240. The Reaction of Unsaturated Carbonyl Compounds with "Activated" Sulfur
  241. Functionalized g-Lactones via Intramolecular Nitrile Oxide Cycloaddition
  242. A New Synthesis of Streptomyces Lactones by 1,3-Dipolar Cycloaddition
  243. Ring-Opening of 4-Isoxazolines: Competitive Formation of Enamino Derivatives and a,b-Enones
  244. Formation of Isoxazolines and Isoxazoles Via Dipolar Cycloaddition by Catalytic Oxidation of Aldoximes with Hydrogen Peroxide and W(Vi) Peroxo Complexes
  245. Novel approach to the ring-opening of 4-isoxazolines: One-pot synthesis of α,β-enones
  246. One-flask transformation of secondary amines to nitrones by oxidation with hydrogen peroxide mediated by triscetylpyridinium tetrakis oxodiperoxotungsto-phosphate (PCWP). Some mechanistic considerations
  247. Rearrangement of o-alkynyl substituted α-diazoacetophenones. Conversion to β-naphthols via arylketene intermediates